Mind Medicine (MindMed) Inc.

NasdaqGS:MNMD Stock Report

Market Cap: US$684.2m

Mind Medicine (MindMed) Dividend

Dividend criteria checks 0/6

Mind Medicine (MindMed) does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield2.4%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-US$1.33
Dividend yield forecast in 3Yn/a

Recent dividend updates

No updates

Recent updates

Mind Medicine: GAD Program Success Continues With BTD And Positive Treatment Data

Apr 04

Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts

Feb 02

Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

May 23
Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely

Feb 07
We're Hopeful That Mind Medicine (MindMed) (NASDAQ:MNMD) Will Use Its Cash Wisely

MindMed: Not The Horse To Back If You're Looking To Buy Psychedelics

Oct 19

MindMed announces proposed public offering of common shares

Sep 27

MindMed doses first patient in phase 1 trial examining psychedelic MDMA-like substances

Sep 20

MindMed regains compliance with Nasdaq's minimum bid price listing requirement

Sep 14

MindMed: Confusing MEME Rally Hides A Company That Looks Empty Of Value

Sep 04

Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

Aug 26
Mind Medicine (MindMed) (NASDAQ:MNMD) Is In A Good Position To Deliver On Growth Plans

Magic mushrooms psychedelic compound can help with treatment of alcohol use disorder

Aug 24

MindMed soars 71% as it appears to be following in Bed Bath & Beyond's footsteps

Aug 18

Mind Medicine GAAP EPS of -$0.04 beats by $0.01

Aug 11

Mind Medicine announces 1-for-15 reverse stock split

Aug 04

MindMed: Another Psychedelic Medicine Play Trading At A Potential Discount

Jul 12

Mind Medicine: It's Best To Stay Far Away From This Risky Psychedelic Stock

Apr 20

MindMed: Falling Uncontrollably

Jan 27

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if MNMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MNMD's dividend payments have been increasing.


Dividend Yield vs Market

Mind Medicine (MindMed) Dividend Yield vs Market
How does MNMD dividend yield compare to the market?
SegmentDividend Yield
Company (MNMD)n/a
Market Bottom 25% (US)1.6%
Market Top 25% (US)4.8%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast in 3 Years (MNMD)n/a

Notable Dividend: Unable to evaluate MNMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MNMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate MNMD's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MNMD has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.